Legionella Testing Market: Opportunities and Forecasts, 2015 - 2023

The Legionella is a rod shaped and gram-negative bacteria that can cause pneumonia (Legionnaires disease) or flu like illness (Pontiac fever). The disease caused by Legionella bacteria is termed as Legionellosis. A Legionella bacterium is a fastidious microorganism and it require special growth requirements for its survival, which include Iron presence, temperature above 68° F, L cysteine and biofilm. However, it can survive at minimal dissolved oxygen levels unlike other microorganisms and is resistant to chlorine disinfection. According to the Centers for Disease Control and Prevention, approximately about 40 different species of Legionella are present and 18 of those are infectious. Among all these species, Legionella pneumophilia bacterium can causes most of the diseases. Initially patients infected show symptoms such as headache, muscle pain, chills and high fever. Later, with the disease progression the patients show symptoms of shortness of breath, chest pain, nausea, vomiting, severe cough and mental changes. The infections caused by Legionella bacterium are categorized in to four types like subclinical infection (infection with no disease), pneumonia (Legionnaires’ disease), extra pulmonary disease and non-pneumonic disease (Pontiac fever).

Download The Full Brouchre of Report: https://goo.gl/bNven3

According to the Centers for Disease Control and Prevention, it has been reported that around 8,000 to 18,000 people are suffering with Legionnaires disease in the United States each year. Among these, in adults, approximately 2 to 15% of patients with community-acquired pneumonia requiring hospitalization and Legionellosis is considered to be the second most common cause of pneumonia that require Intensive Care Unit (ICU) admission. The mortality rate associated with Legionella infection patients is about 5 to 80% and it depends on certain risk factors. These risk factors are associated with the high mortality rate include age, belated antimicrobial therapy for infection and predisposing underlying conditions such as diabetes mellitus, chronic lung disease and immunodeficiency. For the patients with Legionella disease, effective antimicrobial therapy is considered as the standard initial empirical treatment therapy for community-acquired pneumonia (CAP) and for specific patients with nosocomial pneumonia.

Macrolides, quinolones, ketolides, tetracyclines and rifampin are various antibiotics used for the treatment of Legionella infection. Among these, Azithromycin is the drug of choice for treating this infection in children and for adults, certain flouroquinolones like levofloxacin and moxifloxacin are considered as the most efficient drugs. There are various diagnostic tests are available commercially in the market for the detection of Legionella bacterium in the body, which include blood tests, chest X-ray, sputum or lung tissue test and urine antigen tests.

The global market for Legionella testing is expected to record significant growth rate in the near future. The growth would be observed due to advancement in immunodiagnostic technologies and automation. Additionally, growth in this industry would be fuelled by entry of new market players, growing awareness about the disease and outbreaks of the infection in the developing countries. For an instance, according to the National Health Service (NHS), it was estimated that approximately 10 to 15% of people with Legionella infection would die due to severe complications such as lungs failure, kidney’s failure or septic shock. Hence, increasing prevalence of the infection would increase the demand for Legionella testing.

Geographically, North America accounts for the largest share of the Legionella tests market followed by the European region. The dominance of North America in this market is majorly seen due to rising number of patients suffering from Legionella infections and presence of large number of market players in this region. European Legionella tests market follows the North America market due to extensive promotion and funding for healthcare facilities by the European government such as Germany and the U.K.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/legionella-testing-market.html

Some of the major players operating in this market includes Abbott Laboratories, Becton Dickinson, Life Technology, Novartis Diagnostics, Bio-Rad, Beckman Coulter and Roche Diagnostics.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.